Zhejiang Nhu Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhejiang Nhu Co Ltd with three other
companies in this sector in China:
Shandong Xinhua Pharmaceutical Company Limited
sales of 4.52 billion Chinese Renmimbi [US$667.33 million]
of which 44%
China Resources Double-Crane Pharmaceutical Company Limited
(6.42 billion Chinese Renmimbi [US$949.02 million]
of which 68%
was Non- transfusion), and
Apeloa Pharmaceutical Co Ltd
(5.55 billion Chinese Renmimbi [US$820.44 million]
of which 100%
was Health Care & Pharmaceutical).
Zhejiang Nhu Co Ltd reported sales of 6.23 billion Chinese Renmimbi (US$920.14 million)
December of 2017.
increase of 32.6%
versus 2016, when the company's sales were 4.70 billion Chinese Renmimbi.
Sales of Other, Main Operation saw an increase
that was more than double the company's growth rate: sales were up
66.4% in 2017, from
220.92 million Chinese Renmimbi to 367.65 million Chinese Renmimbi.
Not all segments of Zhejiang Nhu Co Ltd experienced an increase in sales in 2017:
sales of Other Operation fell 3.1% to 34.76 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).